Skip to main content
. 2022 May 2;28(5):693–697. doi: 10.14744/tjtes.2021.31766

Table 3.

Patients’ N/L ratios

All patients n (%) Group 1 n (%) Group 2 n (%) p-value
N/L ratio 8.85±6.05 9.1±6.1 8.75±6.15 0.976
(0.49–24.19) (1.26–21.81) (0.49–24.19)

N/L: Neutrophil-lymphocyte.